Bliss GVS Pharma Ltd Share Price
(BLISSGVS)
₹123.09▲1.28%
as on 04:01PM, 29 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 3.2 % |
3 Month Return | -21.3 % |
1 Year Return | -0.41 % |
Market Stats | |
Previous Close | ₹121.54 |
Open | ₹123.00 |
Volume | 2.72L |
Upper Circuit | ₹145.84 |
Lower Circuit | ₹97.23 |
Market Cap | ₹1,297.00Cr |
P/E Ratio
21.71
PEG Ratio
-7.81
Market Cap
₹1,297.00 Cr
P/B Ratio
1.19
EPS
7.79
Dividend Yield
0.44
Sector
Pharmaceuticals
ROE
7.91
Funds | Holdings | Prev. 5M |
---|---|---|
![]() | 0.06% |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 187.77 Cr → 225.68 Cr (in ₹), with an average increase of 8.5% per quarter
Promoter Holding Up
Promoters have increased holdings from 35.10% to 35.29% in Mar 2025 quarter
Retail Holding Up
Retail Investor have increased holdings from 44.84% to 44.98% in Mar 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 86.1%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 53.5%
FII Holding Down
Foreign Institutions have decreased holdings from 13.51% to 13.18% in Mar 2025 quarter
Price Dip
In the last 3 months, BLISSGVS stock has moved down by -17.1%
Profit Down
Netprofit is down for the last 2 quarters, 24.26 Cr → 23.8 Cr (in ₹), with an average decrease of 1.9% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 35.29% | 0.00 | |
Foreign Institutions | 13.18% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 44.98% | 0.00 | |
Others | 6.55% | 0.00 |
Bliss Gvs in the last 5 years
Lowest (7.08x)
August 22, 2019
Today (21.71x)
April 29, 2025
Industry (54.77x)
April 29, 2025
Highest (576.11x)
January 3, 2022
Bliss GVS Pharma Ltd’s net profit fell -13.8% since last year same period to ₹23.80Cr in the Q3 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -1.9% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Bliss GVS Pharma Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.81%.
Read More about DividendsBearish
Neutral
Bullish
Bliss GVS Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹1,297.00 Cr | 5.13% | 0.54 | ₹81 Cr | ₹770 Cr | |
NA | ₹147.07 Cr | 35.43% | 0.62 | NA | NA | |
NA | ₹5,411.31 Cr | 432.02% | 0.50 | ₹33 Cr | ₹204 Cr | |
NA | ₹1,510.04 Cr | 381.87% | 0.52 | NA | NA | |
NA | ₹3,596.41 Cr | 157.18% | 0.51 | NA | NA |
Organisation | Bliss Gvs |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Bliss GVS Pharma Ltd share price today stands at ₹123.09, Open: ₹123, Previous Close: ₹121.54, High: ₹124.1, Low: ₹121.51, 52 Week High: ₹185.5, 52 Week Low: ₹92.15.
Today's traded volume of Bliss GVS Pharma Ltd(BLISSGVS) is 2.72L.
Today's market capitalisation of Bliss GVS Pharma Ltd(BLISSGVS) is ₹1297Cr.
Bliss GVS Pharma Ltd (BLISSGVS) share price is ₹123.09. It is down -33.64% from its 52 Week High price of ₹185.5
Bliss GVS Pharma Ltd (BLISSGVS) share price is ₹123.09. It is up 33.58% from its 52 Week Low price of ₹92.15